Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00227253 · ClinicalTrials.gov registry record
Chromosome 18 Clinical Research Center
A clinical trial of Growth Hormone Deficiency and Chromosome Aberrations, sponsored by The University of Texas Health Science Center at San Antonio.
- Recruiting
- Registry status
- 4,000
- Enrollment target
- 2
- Study locations
NCT00227253: Recruiting study of Growth Hormone Deficiency and Chromosome Aberrations, sponsored by The University of Texas Health Science Center at San Antonio.
NCT00227253 is a study of Growth Hormone Deficiency and Chromosome Aberrations that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 4,000 participants, above the 137-participant average among 16 other Growth Hormone Deficiency trials with a reported enrollment target (2820% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00227253, a study of Growth Hormone Deficiency and Chromosome Aberrations, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.
- RECRUITING
- Registry status
- 4,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
Our vision, that of the researchers at the University of Texas Health Science Center at San Antonio, is that every person with a chromosome 18 abnormality will have an autonomous and healthy life. Our mission is to provide families affected by chromosome 18 abnormalities with comprehensive medical and educational information. Our goals are to provide definitive medical and education resources for the families of individuals with chromosome 18 abnormalities; perform and facilitate groundbreaking clinical and basic research relating to the syndromes of chromosome 18; and to provide treatments to help these individuals overcome the effects of their chromosome abnormality.
Primary Outcome
Provide definitive medical and education resources for the families of individuals with chromosome 18 abnormalities
Conditions Studied
Interventions
- PROCEDURE Determination of growth hormone status
- PROCEDURE Measurement of growth, thyroid and sex hormone levels
- PROCEDURE Behavior and neuropsychometric evaluations
- PROCEDURE Audiological and ear, nose and throat examination
- PROCEDURE Magnetic resonance imaging of the brain
Study Locations (2)
Texas
- University Health Systems Hospital - San Antonio
- University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 1993-09 |
| Est. Completion | 2040-12 |
What NCT00227253 shows while recruiting
NCT00227253 is an observational study that tracks outcomes without assigning an intervention. Its 4,000 participants enrollment target places it among the larger protocols in the corpus, above the 137-participant average among 16 other Growth Hormone Deficiency trials with a reported enrollment target (2820% higher).
The record links to 3 conditions, with Growth Hormone Deficiency appearing as the primary indexed condition, and to 5 interventions - of which Determination of growth hormone status is the first listed.
NCT00227253 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00227253 about?
NCT00227253 is a clinical study titled "Chromosome 18 Clinical Research Center". Our vision, that of the researchers at the University of Texas Health Science Center at San Antonio, is that every person with a chromosome 18 abnormality will have an autonomous and healthy life. Our mission is to provide families affected by chromosome 18 abnormalities with comprehensive medical a...
What is the current status of trial NCT00227253?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 1993-09. Estimated completion is 2040-12.
What conditions does trial NCT00227253 study?
This clinical trial studies the following conditions: Growth Hormone Deficiency, Chromosome Aberrations, Hypomyelination.
What interventions are being tested in trial NCT00227253?
The interventions under investigation include: Determination of growth hormone status (PROCEDURE), Measurement of growth, thyroid and sex hormone levels (PROCEDURE), Behavior and neuropsychometric evaluations (PROCEDURE), Audiological and ear, nose and throat examination (PROCEDURE), Magnetic resonance imaging of the brain (PROCEDURE).
Who is sponsoring clinical trial NCT00227253?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00227253 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Growth Hormone Deficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00227253's enrollment target sits among peer trials
4,000 1st of 16 higher than 16 of 16 other Growth Hormone Deficiency trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Growth Hormone Deficiency trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
RECRUITING
-
A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
RECRUITING
-
Effects of GH and Lirglutide on AgRP
RECRUITING · Phase 4
-
Growth Hormone Replacement Therapy for Retried Professional Football Players
RECRUITING · Phase 2
-
Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213)
COMPLETED · Phase 2
-
Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00811148 · 4,000 participants
Florida Center for Brain Tumor Research
- NCT00897117 · 4,000 participants
Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer
- NCT00899301 · 4,000 participants
Collecting and Storing Tissue Samples From Women With or Without Breast Cancer
- NCT01399385 · 4,000 participants · NA
New Heart Imaging Techniques to Evaluate Possible Heart Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia